We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+0.05%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.55B
AUM Growth
+$59.4M
(+1.7%)
Cap. Flow
+$77M
Cap. Flow
% of AUM
2.17%
Top 10 Holdings %
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
+$138M |
| 2 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$131M |
| 3 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$127M |
| 4 |
MRO
Marathon Oil Corporation
MRO
|
+$123M |
| 5 |
CHX
ChampionX
CHX
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$638M |
| 2 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
+$51.2M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$45.1M |
| 4 |
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
|
+$18.4M |
| 5 |
Norfolk Southern
NSC
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 26.53% |
| 2 | Technology | 21.03% |
| 3 | Healthcare | 14.68% |
| 4 | Industrials | 8.19% |
| 5 | Materials | 6.14% |
Similar funds
FNBT
SAG
ACI
TCOV
RC
A
CGL
CB
UBS O'Connor's Q2 2024 Portfolio in Review
As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.
By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.
- UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
- UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
- UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
- UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
- UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
- UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
- UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.
Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.